Federal Health Minister Jens Spahn (CDU) does not want to touch controversial cost assumptions for homeopathic medicines by the health insurance companies. He pointed out on Tuesday evening in Berlin at the "Berlin Salon" of the editorial network Germany on the fact that the statutory health insurance pays for drug expenditures of about 40 billion euros per year about 20 million for homeopathy. This can be discussed emotionally and can offend many people. Or one could ask oneself whether it is worth considering the whole order of magnitude. He decided it was "so okay".
In Germany, the topic is discussed violently. Those who want to have such means, they should receive, "but please not at the expense of solidarity," said the head of the Association of Statutory Health Insurance Physicians (KBV), Andreas Gassen, recently. He pointed to insufficient scientific evidence for the effectiveness of homeopathic remedies.
SPD parliamentary vice Karl Lauterbach sees it the same way: He wants to prohibit statutory health insurance, the reimbursement of homeopathy. "We have to talk about it in GroKo," he said.
- Read a comment here: Argument # 4 will convince you of homeopathy!
- A column on homeopathy can be found here: State-sponsored magical thinking
Homeopathy is not part of the service catalog of the statutory health insurance. However, many health insurances reimburse treatment costs for natural remedies because there is a demand. This is also an instrument in competition.
In France, homoeopathic medicines will no longer be reimbursed from 2021 onwards. The Supreme Health Authority (HAS) claims to have tested nearly 1,200 homeopathic medicines for nine months and analyzed more than 1,000 scientific publications. In the end, the agency came to the conclusion that efficacy can not be proven. The HAS also emphasized that the use of homeopathy for serious progressive diseases should not delay medically necessary treatment.
The current reimbursement of 30 percent of the costs in France will initially be reduced to 15 percent at the turn of the year. In 2021, there should be no additional costs. Health Minister Agnès Buzyn said the transition phase should give both patients and industry time to prepare.